Big US hedge funds hit hard by Valeant sell-off
- (www.ft.com) Three
of the US’s biggest hedge funds have suffered billions of dollars in losses
from their portfolios thanks to a sharp sell-off in the shares of Valeant Pharmaceuticals. Bill Ackman’s Pershing Square, Jeff Ubben’s
ValueAct, and John Paulson’s Paulson & Co have been hit hard this week
because of their concentrated bets on Valeant, with Mr Ackman holding 30 per
cent of his fund in the pharmaceutical company’s shares. Valeant shares fell a further 5 per cent on Tuesday, adding to a
16.5 per cent plunge on Monday, as investors took fright after Democrat
politicians called for a subpoena to force the company to hand over documents
relating to “massive price hikes” for its drugs. One US-based investor in hedge
funds said: “Large, focused bets on single companies can lead to huge returns
for managers when they go well, but destroy years of gains when they go wrong.
It is always a risky strategy no matter how much of an edge a hedge fund thinks
it has”.
Japanese
Pension Funds Find New Ways To Lose Money, Will Blow Retirement Funds On Junk
Bonds - (www.zerohedge.com) With
Japan's economy already sliding into its 5th recession of the past decade, once
pensioners open their retirement statements in a few weeks and find a 15%
plunge in their purchasing power, Japan can skip recession and proceed straight
to a consumer-driven recession. But wait, there's more: because if pensioners
are angry now, wait until they learn that they have lost everything, after
buying all those junk bonds that Carl Icahn is now actively selling with both
hands and feet, because: JAPAN PENSION FUND TO INVEST IN JUNK BONDS, NIKKEI
SAYS. And just like that, with or without Krugman's active economic
advice, Japan's fate is sealed because much to Japan's dismay, "junk"
bonds are called that for a reason.
The
Martin Shkreli incident could shake up the entire drug industry - (www.businessinsider.com) Last
week, Martin Shkreli got as close to being a household name as any pharma CEO
has in at least the past few decades. Shkreli is the CEO of Turing
Pharmaceuticals, a new company that just bought the US marketing rights to
Daraprim, a drug that fights parasitic infections. Almost immediately,
he hiked the price of the drug up by 5,000% — causing public outrage and
placing political attention on other drugs that have made similar moves. Even
though Shkreli quickly backtracked and
announced that he would lower the price,
the pharmaceutical and biotech industries are still reeling.
IMF warns of coming spike in emerging market
company failures - (www.ft.com) The
International Monetary Fund has warned that emerging economies and bond markets
need to prepare for an increase in corporate failures if and when the US
Federal Reserve and other central banks in advanced economies begin raising rates. The IMF, which has urged the
Fed to wait until next year to raise rates for the first time in almost a
decade, and others have expressed growing concern about the surge in
dollar-denominated debt in emerging economies and the potential impact that a
sudden increase in rates would have. The issue is likely to be among the most
discussed when central bankers and finance ministers from around the world
convene for next week’s annual meetings of the IMF and World Bank in Lima,
Peru. In a chapter of its Global Financial Stability Report prepared for those
meetings and released on Tuesday, IMF economists warn that a surge in corporate
leverage has preceded many emerging market financial crises in history.
Global Rally Shows Relief at End of $11
Trillion Stocks Meltdown - (www.bloomberg.com) From
stocks to commodities to emerging-market currencies, traders got a measure of
solace at the end of the most volatile quarter for financial markets since
2011. Global equities advanced from a two-year low, with U.S.
stocks rising the most since mid-September and European shares surging
with emerging markets. Copper and nickel jumped to ease losses among metals,
while oil traded at the lowest average quarterly price since 2009. The yen
weakened with Treasuries as demand for havens eased for at least a day. With
almost $11 trillion erased from global shares in the three months,
analysts debated whether Wednesday’s rally that stretched from Asia to Europe
and the U.S. will be just a blip. Riskier markets have sold off amid a
prolonged commodity slump, slowing growth in China and an exodus from emerging-market
assets as the U.S. prepared to raise interest rates as soon as this year. Friday’s
payrolls report will show the economy created 200,000 or more jobs for the
sixth month this year, strategists forecast.
Hedge Funds Devise Trades to Benefit From ETFs’ Woes - (online.wsj.com)
Multinational China execs feel chill wind, not hot growth - (www.bloomberg.com)
China sees capital account deficit, volatile fund flows in H2 - (www.reuters.com)
China Cuts Minimum Home Down Payment for First-Time Buyers - (www.bloomberg.com)
Multinational China execs feel chill wind, not hot growth - (www.bloomberg.com)
China sees capital account deficit, volatile fund flows in H2 - (www.reuters.com)
China Cuts Minimum Home Down Payment for First-Time Buyers - (www.bloomberg.com)
No comments:
Post a Comment